Peter Greenleaf
Chief Executive Officer at Aurinia Pharmaceuticals; Director at Pelthos Therapeutics. Based in Durham, North Carolina.
- Rank
- 4052nd of 14,644
- Companies held
- 2
- Largest holding
- AUPH, 99.4% of total
- Latest SEC filing
- Oct 2, 2026
What the $27.7M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals AUPH Common Stock | Directly | 1,840,379 | $14.94 | $27.5M | 99.4% | Form 4, Mar 2, 2026 |
| Pelthos Therapeutics PTHS Common Stock | Directly | 23,087 | $7.20 | $166K | 0.6% | Form 4, Oct 2, 2026 |
Share counts are the amounts Peter Greenleaf reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4049 | Robert L. Johnson Executive Chairman, RLJ Lodging Trust. Bethesda, MD | $27.7M |
| 4050 | Patrick Decker President & CEO, Xylem. Milwaukee, WI | $27.7M |
| 4051 | Pankaj Ramesh Khanna Chief Executive Officer, Heidmar Maritime Holdings | $27.7M |
| 4052 | Peter Greenleaf Chief Executive Officer, Aurinia Pharmaceuticals. Durham, NC | $27.7M |
| 4053 | Martin Migoya Chairman & CEO, Globant | $27.6M |
| 4054 | Doug Jones Director, President & CMBO, PennyMac Financial Services. Westlake Village, CA | $27.6M |
| 4055 | Assaf Ronen Chief Platform Officer, Payoneer Global. New York, NY | $27.6M |
Other Aurinia Pharmaceuticals insiders
All AUPH insiders- Matthew Maxwell Donley$10.2MChief Operating Officer. #8709 overall
- Stephen P. Robertson$8.6MChief Legal Officer. #9832 overall
- Joseph M. Miller$8.6MChief Financial Officer. #9841 overall
- Scott Habig$6.8MChief Commercial Officer. #11653 overall
- George M. Milne Jr.$1.2MDirector. #4890 overall
Questions
How much stock does Peter Greenleaf own?
Peter Greenleaf holds $27,661,489 in listed stock based on SEC filings and current prices, mostly Aurinia Pharmaceuticals (AUPH). That ranks 4052nd on the Stock Rich List.
Is this Peter Greenleaf's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Peter Greenleaf last buy or sell stock?
The most recent open-market trade on file is a sale of 797 PTHS shares on Oct 2, 2026 at $21.17.